Mar 31, 2025 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the BioCardia year-end 2024 financial results and business update conference call. (Operator Instructions) A webcast replay of the call will be available approximately one hour after the end of the call. I would now like to send the call over to Miranda Peto of BioCardia Investor Relations. Please go ahead, Miranda.
Miranda Peto - BioCardia Inc - Investor Relations
Good afternoon and thank you for participating in today's conference call. Joining me from BioCardia's leadership team are Peter Altman, President and Chief Executive Officer, and David McClung, the company's Chief Financial Officer. During this call, management will be making forward-looking statements. Including statements that address BioCardia's expectations for future performance and operational results, references to management, intentions, beliefs, projections, outlook, analysis, and current expectations. Such factors include, among others, the inherent uncertainty associated with developing new products, technologies
Q4 2024 BioCardia Inc Earnings Call Transcript
Apr 01, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers